SlideShare a Scribd company logo
Detecting Acute Coronary Syndrome in the Emergency
Department with Cardiac Magnetic Resonance Imaging
Raymond Y. Kwong MD
Co-Director, Cardiac Magnetic Resonance Imaging
Brigham and Women’s Hospital
Cardiology Grand Round
Beth Israel Deaconess Hospital
April 11th
, 2003
Acknowledgments
NHLBI
• Andrew E. Arai, MD
• Robert S. Balaban, PhD
• Anthony Aletras, PhD
• Adam Schussheim, MD
• Suresh Rekhraj, MD
• W. Patricia Ingkanisorn, MD
• Kenneth Rhoads, MD
Clinical Center
• Janice Davis, RN
• Grace Graninger, RN
Suburban Hospital
• Cardiology
Eugene Passamani, MD
• Emergency Room
Bob Rothstein, MD
• Radiology
Wayne Olan, MD
Susan O’Flahavan, RT
Paul LeBlanc, RT
Gian Serafini, RT
Chris Mancini, RT
Sarah Pirie, RT
Myocardial Infarction and Chest Pain
in the Emergency Room
• 1,100,000 MI per year in the US
About 1/3 will die from their MI *
• 6,200,000 people in the United States suffer
from angina
• 5,000,000 patients are evaluated in ER for
chest pain each year
American Heart Association.
1999 Heart and Stroke Statistical Update.
* Atherosclerosis Risk in Communities
(ARIC) study, NHLBI
The Spectrum of Chest Pain in the ER
Chest Pain
STEMI
NSTEMI
Unstable
Angina
ACS
Troponin
Non-cardiac
Chest Pain
Stable
Angina
Mortality of ER patients with chest pain
Pope et al. NEJM 2000; 342: 1163
Chest Pain in Emergency Department
LCE/NHLBI/NIH
ST Elevation
Acute MI
PTCA or
Thrombolytics
Intermediate
Likelihood CAD
Cardiac
Rx
Non-STE
MI
Unstable
Angina
Low Likelihood
CAD
Cardiac
Enzymes
Regional Wall Motion: SSFP
Dobutamine Stress MRI
Sensitivity 83-86%
Specificity 83-86%
Nagel Circ 1999; 99: 763
Hundley Circ 1999; 100: 1697
Interobserver Variability for Qualitative
Regional Wall Thickening by MRI
1.32.01.61.3SD of Dif
-0.020.01-0.03-0.02Avg Dif
0.950.930.960.95
Correlati
on
Observer
4
Observer
3
Observer
2
Observer
1
Versus
Consensu
s
Sierra-Galan et al. JCMR in press
First Pass
Perfusion RV
LV
Myo
LCE/NHLBI/NIH
Comparison of Endocardial Microsphere Blood Flow
and Endocardial MRI Contrast Enhancement Ratio
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
y = 0.04 + 0.85x
r = 0.92
Endocardial Microsphere Flow (ml/min/g)
MRIEndocardialCER
NHLBI/NIH
Dipyridamole Stress MRI vs PET and QCA
Schwitter et al. Circ 2001; 103:2230
Dipyridamole Stress MRI vs PET and QCA
Schwitter et al. Circ 2001; 103:2230
MRI Vs PET
Sensitivity 91%
Specificity 94%
MRI Vs QCA
Sensitivity 87%
Specificity 85%
Dipyridamole Stress First Pass Perfusion
Myocardial Perfusion Reserve Index
Al-Saadi et al
Circ 2000; 101:1379
MPR +
54
7
MPR -
6
35
Sensitivity 90%
Specificity 83%
CAD+
CAD -
0
50
100
150
200
0 5 10 15 20
Time (s)
SignalIntensity
Width = τ 0
Fermi Function
Decay rate = κ
Flow
0
500
1000
1500
2000
2500
3000
0 5 10 15 20
Time (s)
SignalIntensity
Fermi Function Deconvolution
Estimates Absolute Myocardial Perfusion
(ml/min/g)
Input
Function
Myocardial
Enhancement
Mathematical
Model
Endocardial and Epicardial Analysis
R = 0.92, P< 0.0001 R = 0.95, P < 0.0001
Infarct Size: TTC vs MRI
Kim R. et al. Circulation. 1999;100:1992-2002
Correlation between MRI Infarct Size
and TTC Staining
Kim R. et al. Circulation. 1999;100:1992-2002
Kim RJ et al.
NEJM 2000;343:1445
Irreversible LV Dysfunction: Pre-intervention
After revascularization
Diastole Systole
Diastole Systole
Transmural Hyper
0
20
40
60
80
100
0 1-25 26-50 51-75 76-100
0
20
40
60
80
100
0 1-25 26-50 51-75 76-100
Transmural Extent of Hyperenhancement Predicts
Recovery of Function
Transmural Extent of Hyperenhancement (%)
ContractileRecovery(%)
ContractileRecovery(%)
Kim RJ et al.
NEJM 2000;343:1445
All segments Akinetic or
Dyskinetic
PET vs MRI Viability
Klein et al. Circulation 2002; 105: 162
Microinfarction after PCI associated with
Minor Side Branch Occlusion
Ricciardi. Circulation 2001;103:2780-3
Patient 7: stent in the proximal LAD
and minor side-branch occlusion
Patient 2: stent in the mid-PDA
and minor side-branch occlusion
MI size = 0.7 to 12 g
Comparison of MRI and SPECT for
Detecting Myocardial Infarction
Wagner et al. Lancet 2003; 361: 374
Method: Acute Chest Pain Protocol
Localize Perfusion Function Viability
Time (min)0 10 20 30
Pilot phase
• To determine safety, feasibility, and logistic issues:
• 37 patients presenting with chest pain to the ER were studied.
– Patients were either from the ER or within 72 hours of admission to
the hospital.
» Well tolerated (1 failure to acquire any image due to
clasutophobia)
» 13 cases of AMI with a wide range of troponins all have
abnormal MRI
» Can perform MRI while receiving concurrent IV meds.
Case 1: 60 yo male
Day 2 post acute MI
Troponin 2X ULN
Case 2: 80 yo female
No prior CAD
Chest pain with non-diagnostic EKG admitted 12
hours ago, small NQMI by troponin
Case 2: 70 yo male
No prior CAD
Chest pain with non-diagnostic EKG admitted 12
hours ago, small NQMI by troponin
Hypothesis
• We hypothesized that MRI could effectively
triage patients presenting with possible acute
coronary syndromes in the Emergency Room
Entry Criteria
• 30 minutes of chest pain compatible with
myocardial ischemia
• ECG not diagnostic of ST-elevation MI
Exclusions
• Pacemaker
• Defibrillator
• Other implanted active devices
• Brain aneurysm clips
Method
Prospective observational trial.
• Enrollment from 01/10/2000 to 09/27/2001
• Inclusion criteria:
• Chest pain > 30 minutes without obvious non-cardiac cause
• Exclusion criteria: any of the following
• ECG diagnostic of ST elevation acute myocardial infarction
• Ongoing active chest pain
• Hemodynamic instability
• Contraindications to MRI scanning
• > 12 hours since onset of last chest pain
.
Symptoms Suggestive of ACS
Noncardiac
diagnosis
Stable
Angina
Possible
ACS
Definite
ACS
ACC/AHA
Practice Guidelines
Unstable Angina
And NSTEMI
Circ 2000;102:1193
ST Elevation
MI
Confirmed ACS
ECG Not
Diagnostic
Troponin (-)
Serial
Studies
? Image
Stress
Test
- +
+
- + -
+
Unstable
Angina
ST or T
and/or
Troponin (+)
+
Non-ST
Elevation
MI
-
Method: Prospectively Defined Clinical Endpoints
Acute coronary syndrome (ACS):
Possible or definite ACS according to ACC/AHA
guidelines
Method: Prospectively Defined Clinical Endpoints
Acute coronary syndrome (ACS):
Possible or definite ACS according to ACC/AHA guidelines as
indicated by chest pain > 30 minutes (an entry criteria) AND
either angiographically significant CAD AND/OR significantly
abnormal stress testing performed during index hospitalization
or the subsequent 6- 8 week follow-up period.
Non-ST elevation acute myocardial infarction
(NSTEMI):
Abnormal troponin-I with a temporal pattern consistent with
acute MI and clinical evidence of coronary artery disease
(Coronary angiography, echo, or noninvasive imaging).
Method: Definitions
Angiographically significant CAD =
1) > 50% left main lesion
or 2) > 70% epicardial coronary artery stenosis
Method: Prospectively Defined Abnormal MRI
Abnormal defined by either:
• Regional wall motion abnormality (RWMA), or
• Myocardial hyperenhancement (Hyper).
Reading included perfusion images:
• Although independent diagnoses were not made using
perfusion alone, the perfusion images helped identify
abnormal regions.
TIMI risk score
Antman et al. JAMA 2000; v284;7:835
Results: Study population
• 193 consecutive patients
• 11 refused to participate
• 21 excluded:
–6 hemodynamically unstable
–2 metallic implants
–3 large body size
–10 claustrophobia
• Remaining 161 formed the study cohort.
• All patients underwent conventional cardiac
workup as determined by the admitting
cardiologists or ER physician
161 enrolled
•92 Male : 69 Female
•Age: 59 + 15 years old
•Average # of risk factors: 3.4
•History of prior MI: 25/161
•Median time since ER arrival:
2.7 hours (off hours cases excluded)
6.0 hours (off hours cases included)
•Average MRI scan duration: 38 + 12 minutes
Results: Study population
Patient Follow-up at 6 –8 weeks
161 patients
• 158 (98%) were successfully contacted at 6-8 week follow-up
• 3 were lost to follow-up: all troponin negative, 2 clinical low risk
with normal MRI and 1 high risk with abnormal MRI
Results: Demographic summary
ACS
(n = 25)
No ACS
(n = 136)
p value
Age (yr) 68 + 13 57 + 14 p = 0.0006
Men (%) 60 57 NS
CAD risk factors
Advanced Age (M>45, W>55) (%) 92 68 p = 0.03
Hypertension (%) 56 43 NS
Diabetes (%) 28 10 p < 0.001
Hypercholesterolemia (%) 64 47 NS
CAD in family (%) 32 42 NS
Hx. of smoking (%) 48 39 NS
Total number of CAD risk factors 4.2 3.2 p = 0.003
Characteristics of Chest Pain
Location
Substernal (%) 32 31 NS
Precordial (%) 24 18 NS
Quality
Crushing, heaviness, pressure or tightness (%) 56 54 NS
Radiation to neck/arm (%) 32 31 NS
Dyspnea, diaphoresis, or nausea (%) 32 40 NS
Previous angina (%) 40 12 p = 0.001
Average Chest Pain Score 8.4 7.5 NS ( p= 0.06)
TIMI risk score P < 0.00011.6 + 0.82.5 + 1.2
Table 1. Demographic Summary
ACS
n = 25
68 + 13
28%
40%
8.4
2.5 + 1.2
No ACS
n = 136
57 + 14
10%
12%
7.5
1.6 + 0.8
p value
0.0006
0.001
0.001
0.06
0.0001
Age
Diabetes
HTN
CP Score
TIMI Risk Score
Kwong et al. Circulation 2003; 107:531-7
11620No ACS
421
+ MRI
ACS
- MRI
Results: Qualitative MRI assessment compared with
clinical evaluation ( N = 161)
MRI
History
of MI
ECG Strict
ECG
Initial
Troponin-
I
Peak
Troponin-
I
TIMI
Risk Score
ACS
Sensitivity
(%)
84 28 80 19 16 40 76
Specificity
(%)
85 87 61 95 97 97 52
NonSTE
MI
Sensitivity
(%)
100 30 70 20 44 NA 80
Specificity
(%)
79 85 56 94 97 97 50
IHD
Sensitivity
(%)
91 51 79 14 10 24 81
Specificity
(%)
98 97 67 96 97 97 58
Sensitivity and Specificity for ACS
0
10
20
30
40
50
60
70
80
90
100
MRI ECG ECG
strict
Trop Trop
peak
TIMI
SensitivityorSpecificity(%)
Sensitivity
Specificity
NS
0.001
0.001
0.004
NS
0.001
0.001
0.011
0.001
0.001
Sensitivity
Specificity
Kwong et al. Circulation 2003; 107:531-7
Multivariate Logistic Regression Analysis:
Predict Acute Coronary Syndrome
0
20
40
60
80
100
0 20 40 60 80 100
False Positive Portion
(1 - specificty, %)
TruePositivePortion
(Sensitivity,%)
TIMI Risk Score
NIH with MRI
NIH without MRI
Kwong et al. Circulation 2003; 107:531-7
Detecting CAD by presence of Regional Wall
Motion Abnormality (RWMA)
1231No IHD
864IHD
No RWMARWMADetect IHD
Sensitivity: 89% Specificity: 99%
Regional wall motion images were interpretable in
196/197 patients (99%)
Detecting CAD by Delayed Hyperenhancement
(HYPER)
1121No IHD
2448IHD
HYPERDetect IHD
Sensitivity: 67% Specificity: 99%
No HYPER
Delayed hyperenhancement images were acquired and
interpretable in 185/197 patients (94%)
Methods
Anterior Septum
Lateral wall
RWMA
Inferior Septum
D
S
End-systolic thickness (S) in mm
End-diastolic thickness (D) in mm
Absolute wall thickening in mm = S - D
Systolic diastolic ratio = S/D
Percent change in wall thickening (%) = (S-D)/D x 100%
Methods
0
20
40
60
80
100
0 20 40 60 80 100
False Positive Portion
(1 – specificity, %)
TruePositivePortion
(Sensitivity,%)
0
20
40
60
80
100
0
20
40
60
80
100
0 20 40 60 80 100
False Positive Portion
(1 – specificity, %)
0 20 40 60 80 100
False Positive Portion
(1 – specificity, %)
ACS Non-STE MI IHD
Receiver Operator Characteristic Analysis:
Quantitative Wall Thickening
3220 Kwong et al. Circulation 2003; 107:531-7
84 year old female with
Acute Non-ST Elevation MI
-20
0
20
40
60
80
100
120
140
160
0 10 20 30
Time (image number)
SignalIntensity
-50
0
50
100
150
200
250
300
350
400
450
500
0 10 20 30
Time (image number)
SIIntegral
33%
68 year old female, with 2 hours CP, no risk
factors, nonspecific ECG, and normal troponin
68 year old female, with 2 hours CP, no risk
factors, nonspecific ECG, and normal troponin
A 53 year old female with
3 days of intermittent rest chest pain
A 53 year old female with
3 days of intermittent rest chest pain
A 53 year old female with
3 days of intermittent rest chest pain
Adenosine Stress
Rest SSFP Adenosine Perfusion Gd Hyperenhancement
67 year old female with no prior CAD
+ DM, FMH, Tob, HTN
Troponin (-)
Cath: RCA 99%, Cx 99%, LAD 75%
Cardiac MRI Unit
The General Infirmary at Leeds
Diastolic Systolic
Perfusion
LAD/LCX RCA
Delayed image
MRI
conclusion:
significant
mid RCA
lesion
X-ray angiogram
Comprehensive Approach to Chest Pain:
MRI: Does It Have Any Role?
• ST Elevation MI
• Post-MI risk stratification
• Detection of residual ischemia
• Viability
• Non-ST elevation MI
• Same as ST elevation MI
• Also potential for more rapid diagnosis
• Unstable angina
• Early rest scan to detect evidence of recent ischemia
• Alternatively, scan after excluding MI with a stress test
Conclusions
• Use of cardiac MRI in the ER in assessment of patients
presenting with chest pain and a non-diagnostic ECG is
feasibility and safe.
• Cardiac MRI has high sensitivity and specificity for detecting
ACS, NSTEMI, and IHD in patients with chest pain, and
could provide useful diagnostic information beyond clinical
assessment.
• MRI parameters could be interpreted both qualitatively and
quantitatively with high accuracy in prediction of clinical
endpoints
• Further work is needed to differentiate acute from chronic
myocardial infarction and to improve scan efficiency.
Conclusions
• Add a slide:
The additional benefit of adenosine stress testing
Cost effectiveness of early patient triage translating into
savings in health care cost dollars
12 months prognostic data
Clinical Cases
50 yo male lawyer, atypical chest pain
First troponin negative
60 yo female presenting with an episode of prolonged
chest pain 24 hours ago, then another episode for several
minutes.
60 yo female presenting with “good story” of
unstable angina.
EKG: NSST changes
First troponin 3X ULN
Cath during index hospitalization: NS stenosis
Uneventful at 6 weeks on no medications

More Related Content

What's hot

Remoli Romolo. Rischio Cardiologico Preoperatorio. ASMaD 2012
Remoli Romolo. Rischio Cardiologico Preoperatorio. ASMaD 2012Remoli Romolo. Rischio Cardiologico Preoperatorio. ASMaD 2012
Remoli Romolo. Rischio Cardiologico Preoperatorio. ASMaD 2012Gianfranco Tammaro
 
LANDMARK TRIALS IN STABLE CAD
LANDMARK TRIALS IN STABLE CADLANDMARK TRIALS IN STABLE CAD
LANDMARK TRIALS IN STABLE CAD
Praveen Nagula
 
CT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress TestCT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress Test
ahvc0858
 
Nstemi invasive treatment rationale and timing
Nstemi invasive treatment rationale and timingNstemi invasive treatment rationale and timing
Nstemi invasive treatment rationale and timing
optimacardio
 
Courage TRIAL 2007
Courage TRIAL 2007Courage TRIAL 2007
Courage TRIAL 2007
Valmiki Seecheran
 
Valve disease in the Pandemic
Valve disease in the PandemicValve disease in the Pandemic
Valve disease in the Pandemic
ahvc0858
 
What is the place of CT coronary angiography in ED chest pain?
What is the place of CT coronary angiography in ED chest pain?What is the place of CT coronary angiography in ED chest pain?
What is the place of CT coronary angiography in ED chest pain?
kellyam18
 
Acs ami update-win program - scai 2010
Acs   ami update-win program - scai 2010Acs   ami update-win program - scai 2010
Acs ami update-win program - scai 2010Trimed Media Group
 
Drug-Eluting Stents for Multivessel PCI
Drug-Eluting Stents for Multivessel PCIDrug-Eluting Stents for Multivessel PCI
Drug-Eluting Stents for Multivessel PCI
Sociedad Latinoamericana de Cardiología Intervencionista
 
Surgical or Transcatheter Valve Surgery: What Your Patients Need To Know In A...
Surgical or Transcatheter Valve Surgery: What Your Patients Need To Know In A...Surgical or Transcatheter Valve Surgery: What Your Patients Need To Know In A...
Surgical or Transcatheter Valve Surgery: What Your Patients Need To Know In A...
ahvc0858
 
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
ahvc0858
 
DANISH trial (Cardiology)
 DANISH trial (Cardiology) DANISH trial (Cardiology)
DANISH trial (Cardiology)
PRAVEEN GUPTA
 
Imaging and Clinical Outcome
Imaging and Clinical OutcomeImaging and Clinical Outcome
Imaging and Clinical Outcome
pichearttalk
 
Esc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronaryEsc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronary
Himanshu Rana
 
Dyslipidemia and CVS by Mohit Soni and Chandan Kumar
Dyslipidemia and CVS by Mohit Soni and Chandan KumarDyslipidemia and CVS by Mohit Soni and Chandan Kumar
Dyslipidemia and CVS by Mohit Soni and Chandan Kumar
OlgaGoryacheva4
 
Jose miguel vegas valle sec sept2015
Jose miguel vegas valle sec sept2015Jose miguel vegas valle sec sept2015
Recent CTO publications
Recent CTO publicationsRecent CTO publications
Recent CTO publications
Euro CTO Club
 
Effect of pci on long term survival in patients
Effect of pci on long term survival in patientsEffect of pci on long term survival in patients
Effect of pci on long term survival in patients
Monish Hassan
 
Evidence Based Approach to Pulmonary Thromboembolism
Evidence Based Approach to Pulmonary ThromboembolismEvidence Based Approach to Pulmonary Thromboembolism
Evidence Based Approach to Pulmonary Thromboembolism
Kristopher Maday
 
Dr.amsterdam_Low Risk ED Chest Pain Patients_SJMC Cardiovascular Symposium
Dr.amsterdam_Low Risk ED Chest Pain Patients_SJMC Cardiovascular SymposiumDr.amsterdam_Low Risk ED Chest Pain Patients_SJMC Cardiovascular Symposium
Dr.amsterdam_Low Risk ED Chest Pain Patients_SJMC Cardiovascular SymposiumStJosephsMedicalCenter
 

What's hot (20)

Remoli Romolo. Rischio Cardiologico Preoperatorio. ASMaD 2012
Remoli Romolo. Rischio Cardiologico Preoperatorio. ASMaD 2012Remoli Romolo. Rischio Cardiologico Preoperatorio. ASMaD 2012
Remoli Romolo. Rischio Cardiologico Preoperatorio. ASMaD 2012
 
LANDMARK TRIALS IN STABLE CAD
LANDMARK TRIALS IN STABLE CADLANDMARK TRIALS IN STABLE CAD
LANDMARK TRIALS IN STABLE CAD
 
CT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress TestCT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress Test
 
Nstemi invasive treatment rationale and timing
Nstemi invasive treatment rationale and timingNstemi invasive treatment rationale and timing
Nstemi invasive treatment rationale and timing
 
Courage TRIAL 2007
Courage TRIAL 2007Courage TRIAL 2007
Courage TRIAL 2007
 
Valve disease in the Pandemic
Valve disease in the PandemicValve disease in the Pandemic
Valve disease in the Pandemic
 
What is the place of CT coronary angiography in ED chest pain?
What is the place of CT coronary angiography in ED chest pain?What is the place of CT coronary angiography in ED chest pain?
What is the place of CT coronary angiography in ED chest pain?
 
Acs ami update-win program - scai 2010
Acs   ami update-win program - scai 2010Acs   ami update-win program - scai 2010
Acs ami update-win program - scai 2010
 
Drug-Eluting Stents for Multivessel PCI
Drug-Eluting Stents for Multivessel PCIDrug-Eluting Stents for Multivessel PCI
Drug-Eluting Stents for Multivessel PCI
 
Surgical or Transcatheter Valve Surgery: What Your Patients Need To Know In A...
Surgical or Transcatheter Valve Surgery: What Your Patients Need To Know In A...Surgical or Transcatheter Valve Surgery: What Your Patients Need To Know In A...
Surgical or Transcatheter Valve Surgery: What Your Patients Need To Know In A...
 
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
 
DANISH trial (Cardiology)
 DANISH trial (Cardiology) DANISH trial (Cardiology)
DANISH trial (Cardiology)
 
Imaging and Clinical Outcome
Imaging and Clinical OutcomeImaging and Clinical Outcome
Imaging and Clinical Outcome
 
Esc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronaryEsc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronary
 
Dyslipidemia and CVS by Mohit Soni and Chandan Kumar
Dyslipidemia and CVS by Mohit Soni and Chandan KumarDyslipidemia and CVS by Mohit Soni and Chandan Kumar
Dyslipidemia and CVS by Mohit Soni and Chandan Kumar
 
Jose miguel vegas valle sec sept2015
Jose miguel vegas valle sec sept2015Jose miguel vegas valle sec sept2015
Jose miguel vegas valle sec sept2015
 
Recent CTO publications
Recent CTO publicationsRecent CTO publications
Recent CTO publications
 
Effect of pci on long term survival in patients
Effect of pci on long term survival in patientsEffect of pci on long term survival in patients
Effect of pci on long term survival in patients
 
Evidence Based Approach to Pulmonary Thromboembolism
Evidence Based Approach to Pulmonary ThromboembolismEvidence Based Approach to Pulmonary Thromboembolism
Evidence Based Approach to Pulmonary Thromboembolism
 
Dr.amsterdam_Low Risk ED Chest Pain Patients_SJMC Cardiovascular Symposium
Dr.amsterdam_Low Risk ED Chest Pain Patients_SJMC Cardiovascular SymposiumDr.amsterdam_Low Risk ED Chest Pain Patients_SJMC Cardiovascular Symposium
Dr.amsterdam_Low Risk ED Chest Pain Patients_SJMC Cardiovascular Symposium
 

Viewers also liked

Acute Coronary Syndrome (ACS): Survival of the Species by Dione Nordby MSN, RN
Acute Coronary Syndrome (ACS): Survival of the Species by Dione Nordby MSN, RNAcute Coronary Syndrome (ACS): Survival of the Species by Dione Nordby MSN, RN
Acute Coronary Syndrome (ACS): Survival of the Species by Dione Nordby MSN, RN
Providence Health Care
 
Case scenario Chest pain evaluation for undergraduates by Dr Md Toufiqur Rahman
Case scenario Chest pain evaluation for undergraduates by Dr Md Toufiqur Rahman Case scenario Chest pain evaluation for undergraduates by Dr Md Toufiqur Rahman
Case scenario Chest pain evaluation for undergraduates by Dr Md Toufiqur Rahman
PROFESSOR DR. MD. TOUFIQUR RAHMAN
 
Prehospital Thrombolysis-Time is Muscle and Muscle is Time
Prehospital Thrombolysis-Time is Muscle and Muscle is TimePrehospital Thrombolysis-Time is Muscle and Muscle is Time
Prehospital Thrombolysis-Time is Muscle and Muscle is Time
Apollo Hospitals
 
2013 CONSENSUS STATEMENT ON PHARMACOINVASIVE STRATEGY IN INDIA
2013 CONSENSUS STATEMENT ON PHARMACOINVASIVE STRATEGY IN INDIA2013 CONSENSUS STATEMENT ON PHARMACOINVASIVE STRATEGY IN INDIA
2013 CONSENSUS STATEMENT ON PHARMACOINVASIVE STRATEGY IN INDIA
Praveen Nagula
 
Mi final
Mi finalMi final
Mi final
Rahul Rai
 
acute coronary syndrome (MI)
acute coronary syndrome (MI)acute coronary syndrome (MI)
acute coronary syndrome (MI)
Nur Idris
 
Pharmacoinvasive approach for stemi
Pharmacoinvasive approach for stemiPharmacoinvasive approach for stemi
Pharmacoinvasive approach for stemi
Please hit like if you really liked my PPTs
 
Passive leg raising an indicator of fluid responsiveness in sepsis
Passive leg raising  an indicator of fluid  responsiveness in sepsisPassive leg raising  an indicator of fluid  responsiveness in sepsis
Passive leg raising an indicator of fluid responsiveness in sepsis
Soumar Dutta
 
A magdy when 2 pci after mi
A magdy when 2 pci  after miA magdy when 2 pci  after mi
A magdy when 2 pci after mi
Ahmed Magdy
 
Early reperfusion in myocardial infarction
Early reperfusion in myocardial infarctionEarly reperfusion in myocardial infarction
Early reperfusion in myocardial infarctioncardiositeindia
 
Lecture chest fellow_PSU 2012
Lecture chest fellow_PSU 2012Lecture chest fellow_PSU 2012
Lecture chest fellow_PSU 2012
rungsun bhurayanontachai
 
PCI vs. thrombolysis
PCI vs. thrombolysisPCI vs. thrombolysis
PCI vs. thrombolysis
Ameel Yaqo
 
Thrombolysis vs PCI for STEMI
Thrombolysis vs PCI for STEMIThrombolysis vs PCI for STEMI
Thrombolysis vs PCI for STEMI
Junhao Koh
 
ACC/AHA 2013 STEMI GUIDELINES - SUMMARY & NEW ADDITIONS
ACC/AHA 2013 STEMI GUIDELINES - SUMMARY & NEW ADDITIONSACC/AHA 2013 STEMI GUIDELINES - SUMMARY & NEW ADDITIONS
ACC/AHA 2013 STEMI GUIDELINES - SUMMARY & NEW ADDITIONS
Imran Ahmed
 
Primary Percutaneus coronary intervention
Primary Percutaneus coronary interventionPrimary Percutaneus coronary intervention
Primary Percutaneus coronary intervention
Ramachandra Barik
 
Fluid responsiveness in critically ill patients
Fluid responsiveness in critically ill patientsFluid responsiveness in critically ill patients
Fluid responsiveness in critically ill patientsUbaidur Rahaman
 
Angiography and Angioplasty
Angiography and AngioplastyAngiography and Angioplasty
Angiography and Angioplastysmithjones1990
 
Acute coronary syndrome(STEMI GUIDELINES AND RECENT ADVANCES)
Acute coronary syndrome(STEMI GUIDELINES AND RECENT ADVANCES)Acute coronary syndrome(STEMI GUIDELINES AND RECENT ADVANCES)
Acute coronary syndrome(STEMI GUIDELINES AND RECENT ADVANCES)
Aditya Sarin
 

Viewers also liked (20)

Acute Coronary Syndrome (ACS): Survival of the Species by Dione Nordby MSN, RN
Acute Coronary Syndrome (ACS): Survival of the Species by Dione Nordby MSN, RNAcute Coronary Syndrome (ACS): Survival of the Species by Dione Nordby MSN, RN
Acute Coronary Syndrome (ACS): Survival of the Species by Dione Nordby MSN, RN
 
Case scenario Chest pain evaluation for undergraduates by Dr Md Toufiqur Rahman
Case scenario Chest pain evaluation for undergraduates by Dr Md Toufiqur Rahman Case scenario Chest pain evaluation for undergraduates by Dr Md Toufiqur Rahman
Case scenario Chest pain evaluation for undergraduates by Dr Md Toufiqur Rahman
 
Prehospital Thrombolysis-Time is Muscle and Muscle is Time
Prehospital Thrombolysis-Time is Muscle and Muscle is TimePrehospital Thrombolysis-Time is Muscle and Muscle is Time
Prehospital Thrombolysis-Time is Muscle and Muscle is Time
 
2013 CONSENSUS STATEMENT ON PHARMACOINVASIVE STRATEGY IN INDIA
2013 CONSENSUS STATEMENT ON PHARMACOINVASIVE STRATEGY IN INDIA2013 CONSENSUS STATEMENT ON PHARMACOINVASIVE STRATEGY IN INDIA
2013 CONSENSUS STATEMENT ON PHARMACOINVASIVE STRATEGY IN INDIA
 
Mi final
Mi finalMi final
Mi final
 
acute coronary syndrome (MI)
acute coronary syndrome (MI)acute coronary syndrome (MI)
acute coronary syndrome (MI)
 
Pharmacoinvasive approach for stemi
Pharmacoinvasive approach for stemiPharmacoinvasive approach for stemi
Pharmacoinvasive approach for stemi
 
Passive leg raising an indicator of fluid responsiveness in sepsis
Passive leg raising  an indicator of fluid  responsiveness in sepsisPassive leg raising  an indicator of fluid  responsiveness in sepsis
Passive leg raising an indicator of fluid responsiveness in sepsis
 
A magdy when 2 pci after mi
A magdy when 2 pci  after miA magdy when 2 pci  after mi
A magdy when 2 pci after mi
 
Early reperfusion in myocardial infarction
Early reperfusion in myocardial infarctionEarly reperfusion in myocardial infarction
Early reperfusion in myocardial infarction
 
Lecture chest fellow_PSU 2012
Lecture chest fellow_PSU 2012Lecture chest fellow_PSU 2012
Lecture chest fellow_PSU 2012
 
PCI vs. thrombolysis
PCI vs. thrombolysisPCI vs. thrombolysis
PCI vs. thrombolysis
 
Thrombolysis vs PCI for STEMI
Thrombolysis vs PCI for STEMIThrombolysis vs PCI for STEMI
Thrombolysis vs PCI for STEMI
 
ACC/AHA 2013 STEMI GUIDELINES - SUMMARY & NEW ADDITIONS
ACC/AHA 2013 STEMI GUIDELINES - SUMMARY & NEW ADDITIONSACC/AHA 2013 STEMI GUIDELINES - SUMMARY & NEW ADDITIONS
ACC/AHA 2013 STEMI GUIDELINES - SUMMARY & NEW ADDITIONS
 
Primary Percutaneus coronary intervention
Primary Percutaneus coronary interventionPrimary Percutaneus coronary intervention
Primary Percutaneus coronary intervention
 
Fluid responsiveness in critically ill patients
Fluid responsiveness in critically ill patientsFluid responsiveness in critically ill patients
Fluid responsiveness in critically ill patients
 
Angiography and Angioplasty
Angiography and AngioplastyAngiography and Angioplasty
Angiography and Angioplasty
 
Acute coronary syndrome(STEMI GUIDELINES AND RECENT ADVANCES)
Acute coronary syndrome(STEMI GUIDELINES AND RECENT ADVANCES)Acute coronary syndrome(STEMI GUIDELINES AND RECENT ADVANCES)
Acute coronary syndrome(STEMI GUIDELINES AND RECENT ADVANCES)
 
Angioplasty
AngioplastyAngioplasty
Angioplasty
 
PTCA
PTCAPTCA
PTCA
 

Similar to Detecting acute coronary syndrome

076 cardiac magnetic resonance imaging
076 cardiac magnetic resonance imaging076 cardiac magnetic resonance imaging
076 cardiac magnetic resonance imaging
SHAPE Society
 
Approach to chest pain
Approach to chest painApproach to chest pain
Approach to chest pain
RLHEDFY2teaching
 
Cpqe power point
Cpqe power pointCpqe power point
Cpqe power point
Benjamin Ostro
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
BALASUBRAMANIAM IYER
 
Massive Stroke by Dr Candice Delcourt
Massive Stroke by Dr Candice DelcourtMassive Stroke by Dr Candice Delcourt
Massive Stroke by Dr Candice Delcourt
CICM 2019 Annual Scientific Meeting
 
Echocardiography for Acute Coronary Syndrome
Echocardiography for Acute Coronary SyndromeEchocardiography for Acute Coronary Syndrome
Echocardiography for Acute Coronary Syndrome
PERKI Pekanbaru
 
Nguyen khoi viet cardiac mri for the evaluation of ischemic heart disease jfi...
Nguyen khoi viet cardiac mri for the evaluation of ischemic heart disease jfi...Nguyen khoi viet cardiac mri for the evaluation of ischemic heart disease jfi...
Nguyen khoi viet cardiac mri for the evaluation of ischemic heart disease jfi...
JFIM - Journées Francophones d'Imagerie Médicale
 
Deep dive ACS.pptx
Deep dive ACS.pptxDeep dive ACS.pptx
Deep dive ACS.pptx
OfferArcherZul
 
a212b74434a2a0e4d2bee882e015987d.pdf
a212b74434a2a0e4d2bee882e015987d.pdfa212b74434a2a0e4d2bee882e015987d.pdf
a212b74434a2a0e4d2bee882e015987d.pdf
SuryaRaj73
 
AMIM Février 2017 New diagnostic tools for GCA luqmani marrakesh
AMIM Février 2017 New diagnostic tools for GCA  luqmani marrakesh AMIM Février 2017 New diagnostic tools for GCA  luqmani marrakesh
AMIM Février 2017 New diagnostic tools for GCA luqmani marrakesh
020359
 
2007 terni, corso sulla medicina basata sull'evidenza. l'arresto cardiaco int...
2007 terni, corso sulla medicina basata sull'evidenza. l'arresto cardiaco int...2007 terni, corso sulla medicina basata sull'evidenza. l'arresto cardiaco int...
2007 terni, corso sulla medicina basata sull'evidenza. l'arresto cardiaco int...
Centro Diagnostico Nardi
 
ACS.ppt
ACS.pptACS.ppt
ACS.ppt
hufane1
 
Ac Coronary Syndrome
Ac Coronary SyndromeAc Coronary Syndrome
Ac Coronary Syndromevineet malik
 
Urgent management of tia
Urgent management of tiaUrgent management of tia
Urgent management of tia
uvcd
 
Escaping from Emergency department pitfalls
Escaping from Emergency department pitfallsEscaping from Emergency department pitfalls
Escaping from Emergency department pitfallstaem
 
STROKE
STROKESTROKE
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced CardiomyopathyEMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
Sean M. Fox
 
Cardiac resynctmh
Cardiac resynctmhCardiac resynctmh
Cardiac resynctmh
naveenkrsharma
 

Similar to Detecting acute coronary syndrome (20)

076 cardiac magnetic resonance imaging
076 cardiac magnetic resonance imaging076 cardiac magnetic resonance imaging
076 cardiac magnetic resonance imaging
 
Approach to chest pain
Approach to chest painApproach to chest pain
Approach to chest pain
 
Cpqe power point
Cpqe power pointCpqe power point
Cpqe power point
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
 
Massive Stroke by Dr Candice Delcourt
Massive Stroke by Dr Candice DelcourtMassive Stroke by Dr Candice Delcourt
Massive Stroke by Dr Candice Delcourt
 
Echocardiography for Acute Coronary Syndrome
Echocardiography for Acute Coronary SyndromeEchocardiography for Acute Coronary Syndrome
Echocardiography for Acute Coronary Syndrome
 
Nguyen khoi viet cardiac mri for the evaluation of ischemic heart disease jfi...
Nguyen khoi viet cardiac mri for the evaluation of ischemic heart disease jfi...Nguyen khoi viet cardiac mri for the evaluation of ischemic heart disease jfi...
Nguyen khoi viet cardiac mri for the evaluation of ischemic heart disease jfi...
 
Deep dive ACS.pptx
Deep dive ACS.pptxDeep dive ACS.pptx
Deep dive ACS.pptx
 
a212b74434a2a0e4d2bee882e015987d.pdf
a212b74434a2a0e4d2bee882e015987d.pdfa212b74434a2a0e4d2bee882e015987d.pdf
a212b74434a2a0e4d2bee882e015987d.pdf
 
AMIM Février 2017 New diagnostic tools for GCA luqmani marrakesh
AMIM Février 2017 New diagnostic tools for GCA  luqmani marrakesh AMIM Février 2017 New diagnostic tools for GCA  luqmani marrakesh
AMIM Février 2017 New diagnostic tools for GCA luqmani marrakesh
 
2007 terni, corso sulla medicina basata sull'evidenza. l'arresto cardiaco int...
2007 terni, corso sulla medicina basata sull'evidenza. l'arresto cardiaco int...2007 terni, corso sulla medicina basata sull'evidenza. l'arresto cardiaco int...
2007 terni, corso sulla medicina basata sull'evidenza. l'arresto cardiaco int...
 
ACS.ppt
ACS.pptACS.ppt
ACS.ppt
 
Ac Coronary Syndrome
Ac Coronary SyndromeAc Coronary Syndrome
Ac Coronary Syndrome
 
Urgent management of tia
Urgent management of tiaUrgent management of tia
Urgent management of tia
 
Escaping from Emergency department pitfalls
Escaping from Emergency department pitfallsEscaping from Emergency department pitfalls
Escaping from Emergency department pitfalls
 
STROKE
STROKESTROKE
STROKE
 
Spect ct -dan berman
Spect ct -dan bermanSpect ct -dan berman
Spect ct -dan berman
 
Berman shape 05 fin
Berman shape 05 fin Berman shape 05 fin
Berman shape 05 fin
 
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced CardiomyopathyEMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
 
Cardiac resynctmh
Cardiac resynctmhCardiac resynctmh
Cardiac resynctmh
 

More from Society for Heart Attack Prevention and Eradication

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
Society for Heart Attack Prevention and Eradication
 

More from Society for Heart Attack Prevention and Eradication (20)

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vu lplaque1 pasterkamp
 
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable plaque overview
 
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable patient mar 04
 
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vulnerable (thrombogenic blood
 
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln shape aha 2005
 
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vuln plaque poster burke
 
Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25
 
Vp watch editorial_slide25short-
Vp watch editorial_slide25short-Vp watch editorial_slide25short-
Vp watch editorial_slide25short-
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch2002
 
Vp symposium31602
Vp symposium31602Vp symposium31602
Vp symposium31602
 
Vpschoenhagen
VpschoenhagenVpschoenhagen
Vpschoenhagen
 

Recently uploaded

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 

Detecting acute coronary syndrome

  • 1. Detecting Acute Coronary Syndrome in the Emergency Department with Cardiac Magnetic Resonance Imaging Raymond Y. Kwong MD Co-Director, Cardiac Magnetic Resonance Imaging Brigham and Women’s Hospital Cardiology Grand Round Beth Israel Deaconess Hospital April 11th , 2003
  • 2. Acknowledgments NHLBI • Andrew E. Arai, MD • Robert S. Balaban, PhD • Anthony Aletras, PhD • Adam Schussheim, MD • Suresh Rekhraj, MD • W. Patricia Ingkanisorn, MD • Kenneth Rhoads, MD Clinical Center • Janice Davis, RN • Grace Graninger, RN Suburban Hospital • Cardiology Eugene Passamani, MD • Emergency Room Bob Rothstein, MD • Radiology Wayne Olan, MD Susan O’Flahavan, RT Paul LeBlanc, RT Gian Serafini, RT Chris Mancini, RT Sarah Pirie, RT
  • 3. Myocardial Infarction and Chest Pain in the Emergency Room • 1,100,000 MI per year in the US About 1/3 will die from their MI * • 6,200,000 people in the United States suffer from angina • 5,000,000 patients are evaluated in ER for chest pain each year American Heart Association. 1999 Heart and Stroke Statistical Update. * Atherosclerosis Risk in Communities (ARIC) study, NHLBI
  • 4. The Spectrum of Chest Pain in the ER Chest Pain STEMI NSTEMI Unstable Angina ACS Troponin Non-cardiac Chest Pain Stable Angina
  • 5. Mortality of ER patients with chest pain Pope et al. NEJM 2000; 342: 1163
  • 6. Chest Pain in Emergency Department LCE/NHLBI/NIH ST Elevation Acute MI PTCA or Thrombolytics Intermediate Likelihood CAD Cardiac Rx Non-STE MI Unstable Angina Low Likelihood CAD Cardiac Enzymes
  • 7. Regional Wall Motion: SSFP Dobutamine Stress MRI Sensitivity 83-86% Specificity 83-86% Nagel Circ 1999; 99: 763 Hundley Circ 1999; 100: 1697
  • 8. Interobserver Variability for Qualitative Regional Wall Thickening by MRI 1.32.01.61.3SD of Dif -0.020.01-0.03-0.02Avg Dif 0.950.930.960.95 Correlati on Observer 4 Observer 3 Observer 2 Observer 1 Versus Consensu s Sierra-Galan et al. JCMR in press
  • 10. Comparison of Endocardial Microsphere Blood Flow and Endocardial MRI Contrast Enhancement Ratio 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 y = 0.04 + 0.85x r = 0.92 Endocardial Microsphere Flow (ml/min/g) MRIEndocardialCER NHLBI/NIH
  • 11. Dipyridamole Stress MRI vs PET and QCA Schwitter et al. Circ 2001; 103:2230
  • 12. Dipyridamole Stress MRI vs PET and QCA Schwitter et al. Circ 2001; 103:2230 MRI Vs PET Sensitivity 91% Specificity 94% MRI Vs QCA Sensitivity 87% Specificity 85%
  • 13. Dipyridamole Stress First Pass Perfusion Myocardial Perfusion Reserve Index Al-Saadi et al Circ 2000; 101:1379 MPR + 54 7 MPR - 6 35 Sensitivity 90% Specificity 83% CAD+ CAD -
  • 14. 0 50 100 150 200 0 5 10 15 20 Time (s) SignalIntensity Width = τ 0 Fermi Function Decay rate = κ Flow 0 500 1000 1500 2000 2500 3000 0 5 10 15 20 Time (s) SignalIntensity Fermi Function Deconvolution Estimates Absolute Myocardial Perfusion (ml/min/g) Input Function Myocardial Enhancement Mathematical Model
  • 15. Endocardial and Epicardial Analysis R = 0.92, P< 0.0001 R = 0.95, P < 0.0001
  • 16. Infarct Size: TTC vs MRI Kim R. et al. Circulation. 1999;100:1992-2002
  • 17. Correlation between MRI Infarct Size and TTC Staining Kim R. et al. Circulation. 1999;100:1992-2002
  • 18. Kim RJ et al. NEJM 2000;343:1445 Irreversible LV Dysfunction: Pre-intervention After revascularization Diastole Systole Diastole Systole Transmural Hyper
  • 19. 0 20 40 60 80 100 0 1-25 26-50 51-75 76-100 0 20 40 60 80 100 0 1-25 26-50 51-75 76-100 Transmural Extent of Hyperenhancement Predicts Recovery of Function Transmural Extent of Hyperenhancement (%) ContractileRecovery(%) ContractileRecovery(%) Kim RJ et al. NEJM 2000;343:1445 All segments Akinetic or Dyskinetic
  • 20. PET vs MRI Viability Klein et al. Circulation 2002; 105: 162
  • 21. Microinfarction after PCI associated with Minor Side Branch Occlusion Ricciardi. Circulation 2001;103:2780-3 Patient 7: stent in the proximal LAD and minor side-branch occlusion Patient 2: stent in the mid-PDA and minor side-branch occlusion MI size = 0.7 to 12 g
  • 22. Comparison of MRI and SPECT for Detecting Myocardial Infarction Wagner et al. Lancet 2003; 361: 374
  • 23. Method: Acute Chest Pain Protocol Localize Perfusion Function Viability Time (min)0 10 20 30
  • 24. Pilot phase • To determine safety, feasibility, and logistic issues: • 37 patients presenting with chest pain to the ER were studied. – Patients were either from the ER or within 72 hours of admission to the hospital. » Well tolerated (1 failure to acquire any image due to clasutophobia) » 13 cases of AMI with a wide range of troponins all have abnormal MRI » Can perform MRI while receiving concurrent IV meds.
  • 25. Case 1: 60 yo male Day 2 post acute MI Troponin 2X ULN
  • 26.
  • 27.
  • 28.
  • 29. Case 2: 80 yo female No prior CAD Chest pain with non-diagnostic EKG admitted 12 hours ago, small NQMI by troponin
  • 30.
  • 31. Case 2: 70 yo male No prior CAD Chest pain with non-diagnostic EKG admitted 12 hours ago, small NQMI by troponin
  • 32.
  • 33. Hypothesis • We hypothesized that MRI could effectively triage patients presenting with possible acute coronary syndromes in the Emergency Room
  • 34. Entry Criteria • 30 minutes of chest pain compatible with myocardial ischemia • ECG not diagnostic of ST-elevation MI Exclusions • Pacemaker • Defibrillator • Other implanted active devices • Brain aneurysm clips
  • 35. Method Prospective observational trial. • Enrollment from 01/10/2000 to 09/27/2001 • Inclusion criteria: • Chest pain > 30 minutes without obvious non-cardiac cause • Exclusion criteria: any of the following • ECG diagnostic of ST elevation acute myocardial infarction • Ongoing active chest pain • Hemodynamic instability • Contraindications to MRI scanning • > 12 hours since onset of last chest pain .
  • 36. Symptoms Suggestive of ACS Noncardiac diagnosis Stable Angina Possible ACS Definite ACS ACC/AHA Practice Guidelines Unstable Angina And NSTEMI Circ 2000;102:1193 ST Elevation MI Confirmed ACS ECG Not Diagnostic Troponin (-) Serial Studies ? Image Stress Test - + + - + - + Unstable Angina ST or T and/or Troponin (+) + Non-ST Elevation MI -
  • 37. Method: Prospectively Defined Clinical Endpoints Acute coronary syndrome (ACS): Possible or definite ACS according to ACC/AHA guidelines
  • 38. Method: Prospectively Defined Clinical Endpoints Acute coronary syndrome (ACS): Possible or definite ACS according to ACC/AHA guidelines as indicated by chest pain > 30 minutes (an entry criteria) AND either angiographically significant CAD AND/OR significantly abnormal stress testing performed during index hospitalization or the subsequent 6- 8 week follow-up period. Non-ST elevation acute myocardial infarction (NSTEMI): Abnormal troponin-I with a temporal pattern consistent with acute MI and clinical evidence of coronary artery disease (Coronary angiography, echo, or noninvasive imaging).
  • 39. Method: Definitions Angiographically significant CAD = 1) > 50% left main lesion or 2) > 70% epicardial coronary artery stenosis
  • 40. Method: Prospectively Defined Abnormal MRI Abnormal defined by either: • Regional wall motion abnormality (RWMA), or • Myocardial hyperenhancement (Hyper). Reading included perfusion images: • Although independent diagnoses were not made using perfusion alone, the perfusion images helped identify abnormal regions.
  • 41. TIMI risk score Antman et al. JAMA 2000; v284;7:835
  • 42. Results: Study population • 193 consecutive patients • 11 refused to participate • 21 excluded: –6 hemodynamically unstable –2 metallic implants –3 large body size –10 claustrophobia • Remaining 161 formed the study cohort. • All patients underwent conventional cardiac workup as determined by the admitting cardiologists or ER physician
  • 43. 161 enrolled •92 Male : 69 Female •Age: 59 + 15 years old •Average # of risk factors: 3.4 •History of prior MI: 25/161 •Median time since ER arrival: 2.7 hours (off hours cases excluded) 6.0 hours (off hours cases included) •Average MRI scan duration: 38 + 12 minutes Results: Study population
  • 44. Patient Follow-up at 6 –8 weeks 161 patients • 158 (98%) were successfully contacted at 6-8 week follow-up • 3 were lost to follow-up: all troponin negative, 2 clinical low risk with normal MRI and 1 high risk with abnormal MRI
  • 45. Results: Demographic summary ACS (n = 25) No ACS (n = 136) p value Age (yr) 68 + 13 57 + 14 p = 0.0006 Men (%) 60 57 NS CAD risk factors Advanced Age (M>45, W>55) (%) 92 68 p = 0.03 Hypertension (%) 56 43 NS Diabetes (%) 28 10 p < 0.001 Hypercholesterolemia (%) 64 47 NS CAD in family (%) 32 42 NS Hx. of smoking (%) 48 39 NS Total number of CAD risk factors 4.2 3.2 p = 0.003 Characteristics of Chest Pain Location Substernal (%) 32 31 NS Precordial (%) 24 18 NS Quality Crushing, heaviness, pressure or tightness (%) 56 54 NS Radiation to neck/arm (%) 32 31 NS Dyspnea, diaphoresis, or nausea (%) 32 40 NS Previous angina (%) 40 12 p = 0.001 Average Chest Pain Score 8.4 7.5 NS ( p= 0.06) TIMI risk score P < 0.00011.6 + 0.82.5 + 1.2
  • 46. Table 1. Demographic Summary ACS n = 25 68 + 13 28% 40% 8.4 2.5 + 1.2 No ACS n = 136 57 + 14 10% 12% 7.5 1.6 + 0.8 p value 0.0006 0.001 0.001 0.06 0.0001 Age Diabetes HTN CP Score TIMI Risk Score Kwong et al. Circulation 2003; 107:531-7
  • 48. Results: Qualitative MRI assessment compared with clinical evaluation ( N = 161) MRI History of MI ECG Strict ECG Initial Troponin- I Peak Troponin- I TIMI Risk Score ACS Sensitivity (%) 84 28 80 19 16 40 76 Specificity (%) 85 87 61 95 97 97 52 NonSTE MI Sensitivity (%) 100 30 70 20 44 NA 80 Specificity (%) 79 85 56 94 97 97 50 IHD Sensitivity (%) 91 51 79 14 10 24 81 Specificity (%) 98 97 67 96 97 97 58
  • 49. Sensitivity and Specificity for ACS 0 10 20 30 40 50 60 70 80 90 100 MRI ECG ECG strict Trop Trop peak TIMI SensitivityorSpecificity(%) Sensitivity Specificity NS 0.001 0.001 0.004 NS 0.001 0.001 0.011 0.001 0.001 Sensitivity Specificity Kwong et al. Circulation 2003; 107:531-7
  • 50. Multivariate Logistic Regression Analysis: Predict Acute Coronary Syndrome 0 20 40 60 80 100 0 20 40 60 80 100 False Positive Portion (1 - specificty, %) TruePositivePortion (Sensitivity,%) TIMI Risk Score NIH with MRI NIH without MRI Kwong et al. Circulation 2003; 107:531-7
  • 51. Detecting CAD by presence of Regional Wall Motion Abnormality (RWMA) 1231No IHD 864IHD No RWMARWMADetect IHD Sensitivity: 89% Specificity: 99% Regional wall motion images were interpretable in 196/197 patients (99%)
  • 52. Detecting CAD by Delayed Hyperenhancement (HYPER) 1121No IHD 2448IHD HYPERDetect IHD Sensitivity: 67% Specificity: 99% No HYPER Delayed hyperenhancement images were acquired and interpretable in 185/197 patients (94%)
  • 54. D S End-systolic thickness (S) in mm End-diastolic thickness (D) in mm Absolute wall thickening in mm = S - D Systolic diastolic ratio = S/D Percent change in wall thickening (%) = (S-D)/D x 100% Methods
  • 55. 0 20 40 60 80 100 0 20 40 60 80 100 False Positive Portion (1 – specificity, %) TruePositivePortion (Sensitivity,%) 0 20 40 60 80 100 0 20 40 60 80 100 0 20 40 60 80 100 False Positive Portion (1 – specificity, %) 0 20 40 60 80 100 False Positive Portion (1 – specificity, %) ACS Non-STE MI IHD Receiver Operator Characteristic Analysis: Quantitative Wall Thickening 3220 Kwong et al. Circulation 2003; 107:531-7
  • 56. 84 year old female with Acute Non-ST Elevation MI -20 0 20 40 60 80 100 120 140 160 0 10 20 30 Time (image number) SignalIntensity -50 0 50 100 150 200 250 300 350 400 450 500 0 10 20 30 Time (image number) SIIntegral 33%
  • 57. 68 year old female, with 2 hours CP, no risk factors, nonspecific ECG, and normal troponin
  • 58. 68 year old female, with 2 hours CP, no risk factors, nonspecific ECG, and normal troponin
  • 59. A 53 year old female with 3 days of intermittent rest chest pain
  • 60. A 53 year old female with 3 days of intermittent rest chest pain
  • 61. A 53 year old female with 3 days of intermittent rest chest pain
  • 62. Adenosine Stress Rest SSFP Adenosine Perfusion Gd Hyperenhancement 67 year old female with no prior CAD + DM, FMH, Tob, HTN Troponin (-) Cath: RCA 99%, Cx 99%, LAD 75%
  • 63. Cardiac MRI Unit The General Infirmary at Leeds Diastolic Systolic Perfusion LAD/LCX RCA Delayed image MRI conclusion: significant mid RCA lesion X-ray angiogram
  • 64. Comprehensive Approach to Chest Pain: MRI: Does It Have Any Role? • ST Elevation MI • Post-MI risk stratification • Detection of residual ischemia • Viability • Non-ST elevation MI • Same as ST elevation MI • Also potential for more rapid diagnosis • Unstable angina • Early rest scan to detect evidence of recent ischemia • Alternatively, scan after excluding MI with a stress test
  • 65. Conclusions • Use of cardiac MRI in the ER in assessment of patients presenting with chest pain and a non-diagnostic ECG is feasibility and safe. • Cardiac MRI has high sensitivity and specificity for detecting ACS, NSTEMI, and IHD in patients with chest pain, and could provide useful diagnostic information beyond clinical assessment. • MRI parameters could be interpreted both qualitatively and quantitatively with high accuracy in prediction of clinical endpoints • Further work is needed to differentiate acute from chronic myocardial infarction and to improve scan efficiency.
  • 66. Conclusions • Add a slide: The additional benefit of adenosine stress testing Cost effectiveness of early patient triage translating into savings in health care cost dollars 12 months prognostic data
  • 68. 50 yo male lawyer, atypical chest pain First troponin negative
  • 69.
  • 70.
  • 71. 60 yo female presenting with an episode of prolonged chest pain 24 hours ago, then another episode for several minutes.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76.
  • 77. 60 yo female presenting with “good story” of unstable angina. EKG: NSST changes First troponin 3X ULN
  • 78.
  • 79.
  • 80.
  • 81. Cath during index hospitalization: NS stenosis Uneventful at 6 weeks on no medications

Editor's Notes

  1. Good afternoon, In the first presentation of this session, Dr. Schussheim has presented the results of the pilot phase of our study. I’ d now like to present the midterm results of the prospective phase of our study using cardiac MRI in the ER in evaluating patients presented with chest pain.
  2. According to AHA statistics, there are over 1 million myocardial infarctions in this country per year and a third of them will die from it. There are over 6 million people suffering from angina, and as a result, over 5 million cases of chest pain are evaluated in the emergency rooms each year. This illustrates the burden of chest pain syndromes to the health care system.
  3. According to recent ACC/AHA guidelines, chest pain in the ER could be categorized into 3 risk groups. 10% of patients falls into the high risk group with acute ST elevation on admission EKG diagnostic of acute myocardial infarction. This group needs to be treated without delay and no further diagnostic testing is needed, therefore urgent assessment with MRI has very little role here. In the groups with an intermediate to low clinical suspicion of acute coronary syndromes, at the time when they are diagnostically unknown, MRI may provide useful diagnostic information helpful in early risk stratification and treatment planning.
  4. This slide describes the imaging sequences of the acute chest pain protocol: Rapid localization sequence is followed by myocardial perfusion, function, and viability assessment in that order, over a period of approximately 40 minutes.
  5. We hypothesized that MRI could effectively triage patients presented with possible acute coronary syndromes in the Emergency Room. In the pilot phase we studied 37 patients from different risk groups to make sure we would have a representative sample of normal and abnormal cases in a small sample size. In the prospective phase, at the time of this presentation, we have studied 121 patients over a 10 month period. These are patients presented to the ER with chest pain &amp;gt; 30 minutes and non-dx EKG
  6. We hypothesized that MRI could effectively triage patients presented with possible acute coronary syndromes in the Emergency Room. In the pilot phase we studied 37 patients from different risk groups to make sure we would have a representative sample of normal and abnormal cases in a small sample size. In the prospective phase, at the time of this presentation, we have studied 121 patients over a 10 month period. These are patients presented to the ER with chest pain &amp;gt; 30 minutes and non-dx EKG
  7. This slide illustrates the primary endpoints of our study. The primary endpoints are acute myocardial infarction during index hospitalization, or significant CAD, re-hospitalization for MI, death, or stroke upon 30 day follow-up. Acute myocardial infarction is defined by abnormal elevation of troponin levels concordant with findings on coronary angiography and/or clinical assessment.
  8. This slide illustrates the primary endpoints of our study. The primary endpoints are acute myocardial infarction during index hospitalization, or significant CAD, re-hospitalization for MI, death, or stroke upon 30 day follow-up. Acute myocardial infarction is defined by abnormal elevation of troponin levels concordant with findings on coronary angiography and/or clinical assessment.
  9. This slide illustrates the primary endpoints of our study. The primary endpoints are acute myocardial infarction during index hospitalization, or significant CAD, re-hospitalization for MI, death, or stroke upon 30 day follow-up. Acute myocardial infarction is defined by abnormal elevation of troponin levels concordant with findings on coronary angiography and/or clinical assessment.
  10. This slide explains how we define a MRI study to be abnormal. A cardiac MRI study is abnormal if any one of the following exists: Regional wall motion abnormality regardless of other finding. Myocardial hyperenhancement regardless of other finding. Resting perfusion defect with congruent either RWMA or myocardial hyperenhancement. All readings were done by the consensus of two cardiologists blinded to the endpoints of the studies.
  11. Our scanner is only open from 7 to 7, Monday to Friday, so with the patients presented during offhours included, median time of MRI study from admission was 6 hours. However, that time is really about 2 hours when patients were presented during working hours. Questions: what were your nine risk factors? I retyped the slide. It looks like you are not using the slide layout function in powerpoint to help you deal with text alignment. Ask me sometime to show you what I mean.